Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.550
+0.050 (3.33%)
At close: May 8, 2026, 4:00 PM EDT
1.583
+0.033 (2.13%)
After-hours: May 8, 2026, 7:35 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $23.96 million as of May 8, 2026. Its market cap has increased by 31.63% in one year.
Market Cap
23.96M
Enterprise Value
10.59M
1-Year Change
31.63%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $23.96M, a decrease of -69.81%. That is a compound annual growth rate of -23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 23.96M | 40.42% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 25.59M |
| Curis | 24.66M |
| Marker Therapeutics | 24.34M |
| Outlook Therapeutics | 24.25M |
| Vistagen Therapeutics | 24.19M |
| Lantern Pharma | 23.99M |
| AEON Biopharma | 22.91M |
| VYNE Therapeutics | 22.31M |